Literature DB >> 6405789

Modification of cytochrome P-450 with fluorescein isothiocyanate.

R Bernhardt, N T Ngoc Dao, H Stiel, W Schwarze, J Friedrich, G R Jänig, K Ruckpaul.   

Abstract

Fluorescein isothiocyanate (FITC) has been shown to be selectively attached to the N-terminus of cytochrome P-450 LM2. The N-demethylase activity of cytochrome P-450 LM2 reconstituted systems modified in this way was inhibited by 25%. As revealed by CD measurements the overall conformation as well as the immediate heme environment of cytochrome P-450 LM2 remained unchanged after attachment of the FITC molecule. The binding affinity of modified cytochrome P-450 LM2 toward benzphetamine and aniline and the cumene hydroperoxide- or H2O2-supported N-demethylation of benzphetamine are maintained. However, the introduction of the electron via NADPH-cytochrome P-450 reductase (EC 1.6.2.4) is impaired after modification of the alpha-amino group. The extent of reduced modified cytochrome P-450 LM2 in the cytochrome P-450 reductase-supported reduction reaction is diminished and the half-time of the reduction is increased. The diminished reducibility is ascribed to steric hindrance of groups directly involved in the interaction between cytochrome P-450 LM2 and NADPH-cytochrome P-450 reductase or to blocking of the charge-pair interactions between the alpha-amino group of P-450 LM2 and the respective negatively charged group of NADPH-cytochrome P-450 reductase. By energy-transfer measurements distances between the heme and the alpha-amino group of 2.65 and 3.97 nm for the oligomeric and the monomeric forms of P-450 LM2, respectively, have been determined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405789     DOI: 10.1016/0167-4838(83)90042-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Fluorescence depolarization of actin filaments in reconstructed myofibers: the effect of S1 or pPDM-S1 on movements of distinct areas of actin.

Authors:  Yu S Borovikov; I V Dedova; C G dos Remedios; N N Vikhoreva; P G Vikhorev; S V Avrova; T L Hazlett; B W Van Der Meer
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

2.  Modification of the Mycobacterium bovis extracellular protein MPB70 with fluorescein for rapid detection of specific serum antibodies by fluorescence polarization.

Authors:  M Lin; E A Sugden; M E Jolley; K Stilwell
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

3.  Effect of Ca2+-Mg2+ exchange on the flexibility and/or conformation of the small domain in monomeric actin.

Authors:  M Nyitrai; G Hild; Z Lakos; B Somogyi
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

4.  Thymosin beta4 induces a conformational change in actin monomers.

Authors:  Irina V Dedova; Olga P Nikolaeva; Daniel Safer; Enrique M De La Cruz; Cris G dos Remedios
Journal:  Biophys J       Date:  2005-11-04       Impact factor: 4.033

5.  The signal-anchor sequence of CYP2C1 inserts into the membrane as a hairpin structure.

Authors:  Elzbieta Szczesna-Skorupa; Byron Kemper
Journal:  Biochem Biophys Res Commun       Date:  2011-10-21       Impact factor: 3.575

6.  Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase.

Authors:  Y Omata; R Dai; S V Smith; R C Robinson; F K Friedman
Journal:  J Protein Chem       Date:  2000-01

7.  Conformational dynamics in the F/G segment of CYP51 from Mycobacterium tuberculosis monitored by FRET.

Authors:  Galina I Lepesheva; Matej Seliskar; Charles G Knutson; Nina V Stourman; Damjana Rozman; Michael R Waterman
Journal:  Arch Biochem Biophys       Date:  2007-06-06       Impact factor: 4.013

8.  The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners.

Authors:  Francisco Esteves; Diana Campelo; Bruno Costa Gomes; Philippe Urban; Sophie Bozonnet; Thomas Lautier; José Rueff; Gilles Truan; Michel Kranendonk
Journal:  Front Pharmacol       Date:  2020-03-18       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.